| Authors: |
Cote GM; Mass General Brigham Cancer Institute, Boston MA, United States. Electronic address: Gcote@mgh.harvard.edu., Elliott CF; Berry Consultants, Austin, TX, United States., Lipplaa A; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands., Gelderblom H; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands., Blay JY; Centre Léon Bérard, Lyon, Rhone-Alpes, France., Le Cesne A; International Department, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Duffaud F; APHM Hôpital La Timone and Aix Marseille Universite (AMU), Marseille, France., Kesari S; Asthra Health and Lundquist Institute, Santa Monica, CA, United States., George S; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA, United States., Somaiah N; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Conley AP; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Teleanu MV; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Schlenk RF; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology and Department of Hematology, Oncology, and Rheumatology, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany., Bompas E; Institut de Cancerologie de l'Ouest, Saint Herblain, Pays la Loire, France., Schuetze SM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States., Chugh R; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States., Choy E; Mass General Brigham Cancer Institute, Boston MA, United States., Chemudupati T; Chordoma Foundation, Durham, NC, United States., Lozinsky S; Chordoma Foundation, Durham, NC, United States., Freed DM; Chordoma Foundation, Durham, NC, United States., Sommer J; Chordoma Foundation, Durham, NC, United States., Wendelberger B; Berry Consultants, Austin, TX, United States., Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. |
